Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 5G3 TalkMed > Financial Statement > Income statement
5G3 TalkMed
0.400
+0.020+5.26%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(FY)2020/12/31(Q4)2020/12/31(Q3)2020/09/30
Total revenue
-2.24% 60.75M -18.15% 62.14M -21.54% 17.34M -23.06% 14.12M
Cost of revenue
Gross profit
Operating expense
0.14% 33.32M -3.36% 33.28M -16.11% 7.19M -5.74% 7.98M
Staff costs
0.26% 26.56M 4.42% 26.49M -17.12% 5.2M 6.45% 6.61M
Depreciation and amortization
-29.18% 2.49M 2.57% 3.51M 2.71% 873K 10.20% 951K
-Depreciation
-29.18% 2.49M 2.57% 3.51M 2.71% 873K 10.20% 951K
Rent and land expenses
-2.04% 48K 32.43% 49K 60.00% 16K -33.33% 10K
Other operating expenses
-5.82% 4.86M -9.19% 5.16M 14.50% 1.66M -32.95% 944K
Total other operating income
-67.53% 627K 2,509.46% 1.93M 6,066.67% 555K 1,803.57% 533K
Operating profit
-4.98% 27.42M -30.43% 28.86M -24.97% 10.15M -37.89% 6.14M
Net non-operating interest income expense
-131.18% -58K -79.63% 186K -121.46% -53K -115.33% -42K
Non-operating interest income
-53.03% 333K -45.75% 709K -79.10% 74K -63.35% 140K
Non-operating interest expense
-25.24% 391K 32.74% 523K 18.69% 127K 68.52% 182K
Net investment income
Gain/Loss on financial instruments designated as cash flow hedges
Gain/Loss on derecognition of available-for-sale financial assets
Income from associates and other participating interests
0.92% -1.08M -3.33% -1.09M 112.80% 32K 46.93% -164K
Special income /charges
131.58% 996K -3.15M
Less:Impairment of capital assets
-- 0 -- 3.41M -- -- -- --
Less:Other special charges
-293.68% -996K -- -253K -- -- -- --
Other non-operating income /expenses
Income before tax
9.99% 27.29M -40.01% 24.81M -48.42% 6.98M -39.76% 5.94M
Income tax
-6.87% 5.86M -26.37% 6.29M -22.08% 2.09M -36.32% 1.32M
Net income
15.72% 21.43M -43.56% 18.52M -54.92% 4.89M -40.67% 4.62M
Net income continuous operations
15.72% 21.43M -43.56% 18.52M -54.92% 4.89M -40.67% 4.62M
Noncontrolling interests
13.29% -3.69M -44.38% -4.25M -176.55% -2.01M 23.38% -557K
Net income attributable to the company
10.30% 25.12M -36.31% 22.77M -40.42% 6.9M -39.19% 5.18M
Preferred stock dividends
Other under preferred stock dividend
0 0 0 0
Net income attributable to common stockholders
10.30% 25.12M -36.31% 22.77M -40.42% 6.9M -39.19% 5.18M
Gross dividend payment
Basic earnings per share
9.83% 0.019 -36.40% 0.0173 -40.91% 0.0052 -40.00% 0.0039
Diluted earnings per share
9.88% 0.0189 -36.76% 0.0172 -40.91% 0.0052 -40.00% 0.0039
Dividend per share
-23.68% 0.0145 -7.99% 0.019 0.006 0
Currency Unit
SGDSGDSGDSGD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
TalkMed Group Ltd operates as an investment holding company. The principal activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.
CEO: --
Market: --
Watchlist